JOB DETAILS
Roles and Responsibilities
Initiate Recruitment process from end to end to hire right talent at the right place at the right time.
Active support in MIS and record keeping
Facilitating and coordinating internal and external training programmes.
Support during employee engagement activities like feedback sessions, member recreation and other events etc.
To be a pro-active member of the HCN team to play a pivotal role in redefining HCN policies and practices
To be available on floor to resolve any issues/challenges and maintain employee relations.
To support in creating awareness on HCN Policy, practices across YBL.
To represent the company in a positive, professional manner at all times.
To analyse data for informed decision making
Ability to design employee communications
Any other activity in the interest of YBL.
Desired Candidate Profile
Preferably a Bachelors in Science stream with a Masters Degree in Human Resources
A proven track record of Human Capital Nurturing (HCN) with minimum 2 years of experience will be preferable.
Good English and Hindi language skills (Spoken and Written).
Age will not be constraint in deserving cases
We are gender neutral
An emphatic communicator with pleasant personality.
Knowledge and experience of introducing new ideas to improve employee engagement.
Desired Qualities
Self-driven
Ccommitment
Passionate
Versatile
Integrity
Smart and Hard working
Loyal
Perks and Benefits
Compensation and other perquisites would not be a constraint for the right candidate
COMPANY DETAILS
Yashraj Biotechnology Ltd (YBL) is a research and innovation driven, UL registered and ISO 13485:2016, ISO 9001:2015 and OHSAS 18001:2007 certified company, established in 1999 at Navi Mumbai, Maharashtra, India. YBL also has offices in Germany, USA and South Korea.
Our Vision:
Be the key player in Life Sciences Diagnostics and drive innovation for making a Healthier World
Our Values:
Commitment
We always honor o:ur given commitments to the utmost by not overpromising.
Consistency
We will be consistently consistent in delivering products and services.
Fairness
We create opportunities for our customers, employees and community to speak their mind and have their ideas, opinions and feelings heard and offer them fair solutions – so all can win.
Innovation
We strive for excellence by constantly innovating our products, services and processes and thereby live our motto – A Bio-quest forever.
Responsible Business
We will always do what is right. Profit center conflicts will never get in the way of doing what is right. We will always follow all the laws of the land in spirit and set the highest standards for our products/ services, thereby contributing for making a healthier world.
The Company’s major research, development and production-related activities encompass a whole range of native, recombinant and cell- derived antigens; and monoclonal and polyclonal antibodies. Highest standards of quality and unwavering commitment towards healthcare innovation has enabled YBL to capture some of the biggest market segments for various biomarker antigens and antibodies it develops.
Company encourages and facilitates the creation, discovery, dissemination and application of new knowledge through its unit, and academic alliance initiatives. It has recently committed itself to penetrating the niche area of drug discovery and preclinical drug testing through development of induced pluripotent stem cell derived disease specific models for high-throughput drug screening and toxicology testing. A bio-repository of human clinical specimens from patients with broad clinical categories of cancer has been established to isolate their cellular derivatives for purposes of new drug discovery; personalized medicine for patients; and stem cell and tissue banking.
In addition, the company has initiated R&D for the production of recombinant antibodies using Phage Display Technologies.
Research and production-related work at YBL is approved by the Department of Science and Industrial Research, Ministry of Science and Technology, Government of India.